May 10, 2024 – Page 5 – Goldea Capital

Copper Road Completes Sale of the Copper Road Project

Written by Customer Service on May 10, 2024. Posted in Public Companies.

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, May 10, 2024 (GLOBE NEWSWIRE) — Further to its news releases dated February 14 and April 30, 2024, Copper Road Resources Inc. (TSXV: CRD, OTCQB: SAGGF) (“Copper Road” or the “Company”) is pleased to announce that it has completed the sale of its 100% interest in the 24,000-hectare Copper Road Project located in Batchewana Bay, Ontario to Sterling Metals Corp. (TSXV: SAG, OTCQB: SAGGF) (“Sterling”). Pursuant to the terms of a definitive share purchase agreement dated February 13, 2024 between the Company, Sterling and a wholly-owned subsidiary of the Company (the “Subsidiary”), Sterling acquired the Subsidiary, which holds the Copper Road Project, in...

Subsea7: Subsea Integration Alliance awarded contract offshore Türkiye

Written by Customer Service on May 10, 2024. Posted in Public Companies.

Luxembourg – 10 May 2024 – Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) today announced the award of a large1 contract by Turkish Petroleum Offshore Technology Center AS (TP-OTC) relating to the Sakarya field development in the Black Sea, offshore Türkiye. The award will be booked in backlog in Q2 2024. An initial contract was awarded in May 2023 to a consortium including SLB, Subsea Integration Alliance2 and Saipem for the engineering, procurement, construction and installation of the second development phase (2a) of the Sakarya gas field. Today’s award expands the existing contract with Subsea Integration Alliance to include the installation of Türkiye’s first floating production unit as part of Phase 2a development. Subsea7’s scope will include the installation and integration of risers, umbilicals, hook-ups and mooring systems...

Novaturas will introduce 2024 first quarter results (unaudited)

Written by Customer Service on May 10, 2024. Posted in Public Companies.

On May 22th 2024 at 9:00 AM CEO of AB “Novaturas” Mr. Kristijonas Kaikaris and CFO Mr. Vaidrius Verikas will present the Company’s consolidated financial results for the first quarter of 2024 to investors. We kindly ask to register for the webinar using the link below: https://nasdaq.zoom.us/webinar/register/WN_9f5HjXmfQt210z9xIfpBjQ CFO Vaidrius Verikas +370 646 43758

AB Amber Grid Operating Results for the 1st Quarter of 2024

Written by Customer Service on May 10, 2024. Posted in Public Companies.

AB Amber Grid, legal entity code: 303090867. Address: Laisvės ave. 10, LT-04215 Vilnius, Lithuania. Amber Grid delivers results for the 1st quarter of 2024 prepared according to the International Financial Reporting Standards: • Revenue for the 1st quarter of 2024 EUR 20.6 million (the 1st quarter of 2023 EUR 25.5 million);• Net profit for the 1st quarter of 2024 EUR 4.0 million (the 1st quarter of 2023 EUR 1.8 million);• EBITDA (earnings before interest, taxes, depreciation and amortisation) for the 1st quarter of 2024 EUR 9.0 million (the 1st quarter of 2023 EUR 5.4 million);• Average return on equity (ROE) for the last 12 month as of 31 March 2024 8.3% (as of 31 March 2023 6.8%). Amber Grid adjusted financial indicators for the 1st quarter of 2024: • Adjusted net profit for the 1st quarter of 2024 EUR 3.4 million (the 1st quarter of...

Immix Biopharma Announces Positive NXC-201 Relapsed/Refractory AL Amyloidosis Clinical Data in ASGCT 2024 Late Breaking Oral Presentation

Written by Customer Service on May 10, 2024. Posted in Public Companies.

92% (12/13) overall response rate (ORR) for relapsed/refractory AL Amyloidosis patients enrolled in NEXICART-1: 12 out of 12 patients not exposed to prior BCMA-targeted bispecific responded to NXC-201 (100% ORR), of which 9 out of 12 were complete responders (75% CRs) 1 patient with prior exposure to BCMA-targeted bispecific treatment did not respond Best responder duration of response was 28.0 months with response ongoing as of May 10, 2024 U.S. prevalence of relapsed/refractory AL Amyloidosis is growing 12% per year according to Staron, et al Blood Cancer Journal, estimated to reach 33,277 patients in 2024 LOS ANGELES, May 10, 2024 (GLOBE NEWSWIRE) — Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), a clinical-stage biopharmaceutical company trailblazing cell therapies in autoimmune disease, today announced...

Lincoln Tech Expands its Partnership with the Peterbilt Technician Institute Offering Specialized Training at its Denver Campus

Written by Customer Service on May 10, 2024. Posted in Public Companies.

Parsippany, NJ, May 10, 2024 (GLOBE NEWSWIRE) — Lincoln Educational Services Corporation (NASDAQ: LINC), a national leader in specialized technical training for more than 75 years, has expanded its training partnership with Peterbilt Motors Company to offer specialized diesel technician training at its Denver, CO campus. The Peterbilt Technician Institute (PTI) at Lincoln Tech will assist Lincoln graduates in building additional skills for Peterbilt-specific equipment and technologies, and in starting new careers at Peterbilt locations across the country. This is the second Lincoln Tech location to offer PTI training; the program was introduced at Lincoln’s Nashville, TN campus last spring. “We’re excited to be able to expand our relationship with Peterbilt to the Denver campus,” says Susan English, Lincoln Tech’s Senior Vice President...

Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates

Written by Customer Service on May 10, 2024. Posted in Earnings Releases And Operating Results.

WALTHAM, Mass., May 10, 2024 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced financial results for the first quarter ended March 31, 2024, and recent corporate updates. James F. Oliviero, President and Chief Executive Officer of Checkpoint, said, “Over the past few months, we have worked closely with our third-party contract manufacturing organization (“CMO”) for cosibelimab to resolve their inspection deficiencies noted in the complete response letter (“CRL”) we received from the U.S. Food and Drug Administration (“FDA”) last December. Recently, our CMO submitted to FDA their response to the inspection deficiencies, which we believe could allow for the resubmission of our biologics license application (“BLA”). We plan...

Global Ship Lease Declares Quarterly Dividend per Common Share for First Quarter of 2024

Written by Customer Service on May 10, 2024. Posted in Dividend Reports And Estimates.

ATHENS, Greece, May 10, 2024 (GLOBE NEWSWIRE) — Global Ship Lease, Inc. (NYSE:GSL) (the “Company”), a containership charter owner, announced today that the Company’s Board of Directors has declared a dividend of $0.375 per Class A common share for the first quarter of 2024, to be paid on June 3, 2024 to shareholders of record as of May 24, 2024. About Global Ship Lease Global Ship Lease is a leading independent owner of containerships with a diversified fleet of mid-sized and smaller containerships. Incorporated in the Marshall Islands, Global Ship Lease commenced operations in December 2007 with a business of owning and chartering out containerships under fixed-rate charters to top tier container liner companies. It was listed on the New York Stock Exchange in August 2008. As at December 31, 2023, Global Ship Lease owned 68 containerships,...

Regarding the election of the Chairman of the Board of Amber Grid

Written by Customer Service on May 10, 2024. Posted in Public Companies.

AB Amber Grid, legal entity code: 303090867. Address: Laisvės ave. 10, LT-04215 Vilnius, Lithuania. On the 10th of May, 2024 at the Board meeting of Amber Grid, Paulius Butkus, Head of Development and Innovation at EPSO-G, was elected as the Chairman of the Board of Amber Grid. More information:Laura Šebekienė, Head of Communications of Amber Grid,Ph. +370 699 61 246, e-mail: l.sebekiene@ambergrid.lt Attachment Paulius Butkus elected as a Chairman of the Board of Amber Grid

Litgrid AB results for the three months of 2024

Written by Customer Service on May 10, 2024. Posted in Public Companies.

Lithuanian electricity transmission system operator LITGRID AB (company code 302564383, registered office address Karlo Gustavo Emilio Manerheimo str. 8, Vilnius, Lithuania) is publishing results of the Company for the three months of 2024. Main financial indicators Q1 2024 Q1 2023 Revenue, EUR million 113.0 86.8 EBITDA, EUR million 29.4 19.7 Net profit, EUR million 21.5 12.9 ROE (for the last 12 months), percents 25.9 -17,3 Adjusted* EBITDA, EUR million 12.8 9.4 Adjusted* Net profit, EUR million 7.4 4.0 Adjusted* ROE (for the last 12 months), percents 11.5 6.0 *The adjustment of income, costs and profitability indicators is carried out due to temporary regulatory difference from the regulated profitability approved by NERC. The indicators are adjusted by the correction...

Day: May 10, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice